Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M726Revenue $M71.2Net Margin (%)-40.0Z-Score0.9
Enterprise Value $M827EPS $-0.7Operating Margin %-41.7F-Score1
P/E(ttm))0Cash Flow Per Share $0.2Pre-tax Margin (%)-43.5Higher ROA y-yN
Price/Book4.410-y EBITDA Growth Rate %0Quick Ratio4.1Cash flow > EarningsY
Price/Sales7.25-y EBITDA Growth Rate %-53.7Current Ratio4.7Lower Leverage y-yN
Price/Cash Flow73.5y-y EBITDA Growth Rate %0ROA % (ttm)-15.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-29.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.1ROI % (ttm)-21.0Gross Margin Increase y-yN

Gurus Latest Trades with FLDM

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
FLDMPRIMECAP Management 2013-06-30 Add0.02%$16 - $19.04
$ 25.4645%Add 31.95%3,746,323
FLDMPRIMECAP Management 2013-03-31 Add0.04%$14.27 - $19.38
$ 25.4651%Add 113.65%2,839,232
FLDMPRIMECAP Management 2012-12-31 Add0.03%$13.63 - $17.02
$ 25.4672%Add 495.25%1,328,900
FLDMPRIMECAP Management 2012-09-30 Buy 0.01%$12.8 - $17.15
$ 25.4672%New holding, 223250 sh.223,250
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

FLDM is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
FLDM PRIMECAP Management 2014-06-303,651,33213.010.12+4.78%
Premium Most recent portfolio changes are included for Premium Members only!

FLDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Smith William MaxwellEVP, LEGAL AFFAIRS & GC 2014-09-15Sell3,000$30.83-11.74view
JOG VIKRAMCHIEF FINANCIAL OFFICER 2014-09-08Sell3,950$28.57-4.76view
Worthington Gajus VincentPRESIDENT & CEO 2014-09-02Sell6,000$28.16-3.37view
Smith William MaxwellEVP, LEGAL AFFAIRS & GC 2014-08-15Sell3,000$27.85-2.3view
JOG VIKRAMCHIEF FINANCIAL OFFICER 2014-08-07Sell3,733$26.343.3view
Worthington Gajus VincentPRESIDENT & CEO 2014-08-06Sell6,000$26.532.56view
Smith William MaxwellEVP, LEGAL AFFAIRS & GC 2014-07-15Sell3,000$31.98-14.92view
JOG VIKRAMCHIEF FINANCIAL OFFICER 2014-07-07Sell5,427$30.61-11.11view
Worthington Gajus VincentPRESIDENT & CEO 2014-07-01Sell6,000$29.72-8.45view
Smith William MaxwellEVP, LEGAL AFFAIRS & GC 2014-06-16Sell3,000$27.64-1.56view

Press Releases about FLDM :

    Quarterly/Annual Reports about FLDM:

    News about FLDM:

    Articles On GuruFocus.com

    More From Other Websites
    FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Sep 19 2014
    Fluidigm’s New JunoTM System Shatters Barriers For SNP Genotyping Sep 16 2014
    Fluidigm Corp. (FLDM) Worth Watching: Stock Up 5.1% Sep 03 2014
    Fluidigm to Present at the Morgan Stanley Global Healthcare Conference Sep 02 2014
    FLUIDIGM CORP Financials Aug 09 2014
    UCSF/Fluidigm Paper Proves Shallow Sequencing of Related Single Cells Sufficient to Harvest... Aug 06 2014
    FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report Aug 04 2014
    FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 31 2014
    Fluidigm Reports Q2 2014 Results Jul 31 2014
    Fluidigm Announces Early Access Program for New Imaging Mass Cytometry Platform Jul 31 2014
    Q2 2014 Fluidigm Corp Earnings Release - After Market Close Jul 31 2014
    Fluidigm to Announce Q2 2014 Financial Results and Host Conference Call for Investors Jul 23 2014
    Fluidigm expected to report strong quarter at Piper Jaffray Jul 10 2014
    Single-Cell mRNA Sequencing Helps Reveal the Role of “Precocious” Dendritic Cells in... Jun 30 2014
    FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Jun 10 2014
    Fluidigm Ships FLEXsixTM Integrated Fluidic Circuits to Genotyping and Gene Expression Customers Jun 03 2014
    FLUIDIGM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 28 2014
    FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report May 12 2014
    Fluidigm to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference May 06 2014
    Fluidigm's (FLDM) CEO Gajus Worthington on Q1 2014 Results - Earnings Call Transcript May 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial